2′-Hydroxyflavanone induced changes in the proteomic profile of breast cancer cells
- 21 September 2018
- journal article
- research article
- Published by Elsevier in Journal of Proteomics
- Vol. 192, 233-245
Abstract
No abstract availableKeywords
Funding Information
- Department of Defense (W81XWH-16-1-0641)
- Beckman Research Institute
This publication has 101 references indexed in Scilit:
- Activation of Akt, mTOR, and the estrogen receptor as a signature to predict tamoxifen treatment benefitBreast Cancer Research and Treatment, 2012
- Detailed Structural-Functional Analysis of the Krüppel-like Factor 16 (KLF16) Transcription Factor Reveals Novel Mechanisms for Silencing Sp/KLF Sites Involved in Metabolism and EndocrinologyJournal of Biological Chemistry, 2012
- The translational landscape of mTOR signalling steers cancer initiation and metastasisNature, 2012
- Ubiquitin-recognition protein Ufd1 couples the endoplasmic reticulum (ER) stress response to cell cycle controlProceedings of the National Academy of Sciences, 2011
- 2'-Hydroxyflavanone inhibits proliferation, tumor vascularization and promotes normal differentiation in VHL-mutant renal cell carcinomaCarcinogenesis, 2011
- Cooperative interaction between retinoic acid receptor-α and estrogen receptor in breast cancerGenes & Development, 2010
- AP4 encodes a c-MYC-inducible repressor of p21Proceedings of the National Academy of Sciences, 2008
- How basal are triple‐negative breast cancers?International Journal of Cancer, 2008
- Let-7 expression defines two differentiation stages of cancerProceedings of the National Academy of Sciences, 2007
- Uracil–DNA glycosylases SMUG1 and UNG2 coordinate the initial steps of base excision repair by distinct mechanismsNucleic Acids Research, 2007